IT1392492B1 - Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa. - Google Patents

Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.

Info

Publication number
IT1392492B1
IT1392492B1 ITMI2008A002330A ITMI20082330A IT1392492B1 IT 1392492 B1 IT1392492 B1 IT 1392492B1 IT MI2008A002330 A ITMI2008A002330 A IT MI2008A002330A IT MI20082330 A ITMI20082330 A IT MI20082330A IT 1392492 B1 IT1392492 B1 IT 1392492B1
Authority
IT
Italy
Prior art keywords
latanoprost
purification
pgf2alfa
prostaglandina
synthetic analogue
Prior art date
Application number
ITMI2008A002330A
Other languages
English (en)
Inventor
Francesca Costantino
Brisco Roberto Di
Original Assignee
Ind Chimica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Chimica Srl filed Critical Ind Chimica Srl
Priority to ITMI2008A002330A priority Critical patent/IT1392492B1/it
Priority to AT09180333T priority patent/ATE536341T1/de
Priority to EP09180333A priority patent/EP2208724B1/en
Publication of ITMI20082330A1 publication Critical patent/ITMI20082330A1/it
Priority to HK11100478.8A priority patent/HK1146267A1/xx
Application granted granted Critical
Publication of IT1392492B1 publication Critical patent/IT1392492B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI2008A002330A 2008-12-24 2008-12-24 Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa. IT1392492B1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI2008A002330A IT1392492B1 (it) 2008-12-24 2008-12-24 Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.
AT09180333T ATE536341T1 (de) 2008-12-24 2009-12-22 Verfahren zur reinigung von latanoprost
EP09180333A EP2208724B1 (en) 2008-12-24 2009-12-22 Process for purification of latanoprost, synthetic analogue of prostaglandin PGF 2alfa
HK11100478.8A HK1146267A1 (en) 2008-12-24 2011-01-18 Process for purification of latanoprost, synthetic analogue of prostaglandin pgf 2alfa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2008A002330A IT1392492B1 (it) 2008-12-24 2008-12-24 Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.

Publications (2)

Publication Number Publication Date
ITMI20082330A1 ITMI20082330A1 (it) 2010-06-25
IT1392492B1 true IT1392492B1 (it) 2012-03-09

Family

ID=41171094

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2008A002330A IT1392492B1 (it) 2008-12-24 2008-12-24 Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.

Country Status (4)

Country Link
EP (1) EP2208724B1 (it)
AT (1) ATE536341T1 (it)
HK (1) HK1146267A1 (it)
IT (1) IT1392492B1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU231214B1 (hu) 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására
CN112851510B (zh) * 2021-01-27 2022-07-19 Agc株式会社 他氟前列素的纯化方法
CN112832150B (zh) * 2021-01-27 2022-06-24 中交第三公路工程局有限公司 一种涵洞通道等立面垂直凿毛装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2186670T3 (es) 1988-09-06 2003-05-16 Pharmacia Ab Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
HU212570B (en) 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
IL134241A (en) 2000-01-27 2006-06-11 Finetech Pharmaceutical Ltd Process for the preparation of latanoprost
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
IL159632A0 (en) 2001-07-17 2004-06-01 Upjohn Co Process and intermediates to prepare latanoprost
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
ITRM20050231A1 (it) 2005-05-13 2006-11-14 Technopharma Sa Procedimento per la sintesi di derivati delle prostaglandine f.

Also Published As

Publication number Publication date
HK1146267A1 (en) 2011-05-27
ITMI20082330A1 (it) 2010-06-25
ATE536341T1 (de) 2011-12-15
EP2208724B1 (en) 2011-12-07
EP2208724A1 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
EA201071413A1 (ru) Способ и композиция для лечения повышения внутриглазного давления и глаукомы
CY1114638T1 (el) Νεοι παρεμποδιστες διαυλων νατριου καλυμμενης πυραζινοϋλογουανιδινης
ATE439798T1 (de) Endoskopisches instrument
BRPI0921830A8 (pt) Composição para tratamento bucal compreendendo sílica fundida
NZ599979A (en) Flexible forehead support
CY1112906T1 (el) Αναστολεις διαυλου νατριου
GT200500296A (es) Sintesis asimetrica de derivados del dehidrobenzofurano
MX2010002565A (es) Acidos 6-fenilnicotinicos substituidos y su uso.
EA201101015A1 (ru) Способ получения бивалирудина
IT1392492B1 (it) Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.
IL214863A0 (en) Polymer fiber, its use and process for its manufacture
AR057526A1 (es) Metodos para la produccion de composiciones oftalmicas oxidativamente estables
WO2010109476A3 (en) Improved process for the preparation of prostaglandins and analogues thereof
AR093042A1 (es) Derivados de etinilo
GT200900287A (es) Extrudidos con enmascaramiento del sabor mejorado
EP2517732A4 (en) TRANSNASAL MARKING COMPOSITION FOR CENTRAL NERVOUS SYSTEM FABRICS, MARKING METHOD, AND SCREENING METHOD, EACH USING THE TRANSNASAL MARKING COMPOSITION FOR CENTRAL NERVOUS SYSTEM TISSUES
WO2011095990A3 (en) Process for the purification of prostaglandins and analogues thereof
EA201001405A1 (ru) Стимуляторы секреции инсулина - производные пиридопиразинонов, способы их получения и их применение для лечения диабета
EA201300440A1 (ru) Способ получения (3s,3s&#39;) 4,4&#39;-дисульфандиилбис(3-аминобутан-1-сульфокислоты)
ATE518828T1 (de) Ein-topf-verfahren zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat
ECSP066597A (es) Método para producir derivados de (3-oxo-2,3-dihidro-1h-isoindol-1-il)-acetilguanidina
DE50302888D1 (de) Verfahren zur herstellung reiner thioctsäure
BR112015014440A2 (pt) processo para a produção de uma solução aquosa purificada de peróxido de hidrogênio
AR093043A1 (es) Derivados de etinilo
ITMI20032024A1 (it) Procedimento per la preparazione dello z-flupentixol